10-Q: Aveanna Healthcare Reports Strong Q3 Growth, Debt Refinancing

Aveanna Healthcare Holdings Inc. reported significant revenue and net income increases for Q3 2025, driven by acquisitions and improved rates, alongside a major debt refinancing.

Summary

• Revenue for the three-month period ended September 27, 2025, increased by $112.9 million, or 22.2%, to $621.9 million, compared to $509.0 million in the prior year.
• Net income for Q3 2025 was $14.1 million, a substantial improvement from a net loss of $42.8 million in Q3 2024.
• Operating income rose by $19.6 million, or 57.5%, to $53.6 million for Q3 2025, up from $34.0 million in Q3 2024.
• For the nine-month period ended September 27, 2025, revenue increased by $266.1 million, or 17.7%, to $1,770.7 million.
• Net income for the nine-month period was $46.3 million, compared to a net loss of $40.1 million in the prior year period.
• The Private Duty Services (PDS) segment saw revenue growth of 25.6% in Q3 2025, primarily due to the Thrive acquisition and increased demand for non-clinical services.
• The Home Health & Hospice (HHH) segment's revenue increased by 15.3% in Q3 2025, driven by a 14.2% increase in total episodes and improved patient mix.
• The Medical Solutions (MS) segment experienced a slight revenue decrease of 0.5% in Q3 2025, attributed to a volume decline partially offset by a revenue rate increase.
• Gross margin percentage improved to 32.6% in Q3 2025 from 31.4% in Q3 2024.
• The company completed the acquisition of Thrive Skilled Pediatric Care, LLC on June 2, 2025, for approximately $75.7 million, including 11.2 million shares of common stock.
• A significant debt refinancing was completed on September 17, 2025, replacing existing term loans and a second lien term loan with new 2025 Term Loans totaling $1,325.0 million and a $250.0 million 2025 Refinancing Revolving Credit Facility.
• The debt refinancing resulted in a $5.9 million loss on debt extinguishment for Q3 and 9M 2025.
• The Securitization Facility was amended on June 25, 2025, increasing the maximum available amount from $225.0 million to $275.0 million and extending its termination date to June 25, 2028.
• As of September 27, 2025, cash and cash equivalents stood at $145.9 million, up from $84.3 million at December 28, 2024.
• Total stockholders' equity moved from a deficit of $123.6 million at December 28, 2024, to a positive $9.2 million at September 27, 2025.

Sentiment

Score: 7

Explanation: The company demonstrated strong financial performance with significant revenue and net income growth, successfully refinanced its debt, and moved to positive equity. However, regulatory headwinds in the home health sector and ongoing legal investigations present notable future uncertainties.

Positives

• Achieved substantial net income of $14.1 million in Q3 2025, a significant turnaround from a $42.8 million net loss in Q3 2024.
• Reported strong revenue growth of 22.2% in Q3 2025 and 17.7% for the nine-month period, indicating robust business expansion.
• Successfully acquired Thrive Skilled Pediatric Care, LLC, contributing to PDS segment volume and revenue growth.
• Improved gross margin percentage to 32.6% in Q3 2025 and 33.7% for the nine-month period, reflecting better operational efficiency and pricing.
• Reduced branch and regional administrative expenses as a percentage of revenue, demonstrating leverage of administrative structure.
• Completed a comprehensive debt refinancing, extending maturity dates for term loans to September 2032 and revolving credit to September 2030, improving the company's debt profile.
• Increased the Securitization Facility to $275.0 million, enhancing liquidity and financial flexibility.
• Transitioned from a stockholders' deficit of $123.6 million to a positive equity of $9.2 million, indicating improved financial health.
• Net cash provided by operating activities significantly increased to $76.1 million for the nine-month period, up from $19.2 million in the prior year.

Negatives

• Incurred a $5.9 million loss on debt extinguishment in Q3 2025 due to the debt refinancing.
• Corporate expenses increased by 63.0% in Q3 2025, primarily due to professional services for refinancing and Thrive integration costs.
• The Medical Solutions segment experienced a slight revenue decline of 0.5% in Q3 2025 due to a decrease in unique patients served.
• CMS's proposed rule for CY 2026 home health prospective payment system is estimated to reduce home health payments by 6.4%, which would negatively affect the HHH segment.
• The One Big Beautiful Bill Act (OBBBA) is projected to reduce federal Medicaid spending by $1.15 trillion over ten years, potentially impacting future Medicaid-funded service rate expansion.
• Ongoing legal proceedings, including a DOJ Antitrust Division subpoena and a Civil Investigation Demand regarding Medicare claims and referrals, introduce regulatory uncertainty and potential future liabilities.

Risks

• Intense competition among home health, hospice, and durable medical equipment companies.
• Ability to maintain relationships with existing patient referral sources.
• Reliance on third-party payers (Medicare, Medicaid, private health insurance) for funding, including changes from the One Big Beautiful Bill Act.
• Changes to Medicare or Medicaid rates or payment methodologies, and the proliferation of Medicare Advantage plans, could exert downward pressure on reimbursement.
• Limited ability to control reimbursement rates for services.
• Delays in collection or non-collection of patient accounts receivable, especially during business integration or system transitions.
• Healthcare reform and other regulations, including proposed rules for the home health prospective payment system by CMS.
• Changes in patient case-mix, payer mix, and payment methodologies.
• Potential reduction in net reimbursement if value-based care programs are not effectively implemented.
• Material adverse effects from public health emergencies, such as pandemics.
• Shortages in qualified employees and management, and competition for qualified personnel.
• Failure to maintain security and functionality of information systems or defend against cybersecurity attacks.
• Substantial indebtedness increases vulnerability to adverse economic conditions and may limit strategic alternatives.
• Ability to identify, finance, acquire, and integrate strategic businesses or assets.
• Risks related to legal proceedings, claims, and governmental inquiries, with potential liabilities exceeding insurance coverage.

Future Outlook

The company anticipates a negative impact on its Home Health & Hospice segment reimbursement rates in CY 2026 due to CMS's proposed rule, estimating a 6.4% reduction. The One Big Beautiful Bill Act is expected to reduce federal Medicaid spending, which may indirectly affect future rate expansion for Medicaid-funded services, though a favorable impact to cash taxes paid is expected for fiscal year 2025. Management believes operating cash flows, available cash, and credit facilities will be sufficient for the next twelve months, but future capital requirements depend on acquisitions and operational results.

Management Comments

• Management believes our platform creates sustainable competitive advantages that support our ability to continue driving rapid growth, both organically and through acquisitions, and positions us as the partner of choice for the patients we serve.
• We have partnered with our industry advocates and others to share comments with CMS on the proposed rule.
• Management believes that a loss event is not probable for the DOJ Antitrust Division investigation and the Civil Investigation Demand regarding Comfort Care Hospice, and that these matters will not materially impact the company's business, results of operations or financial condition.

Industry Context

The U.S. healthcare industry, particularly home health and hospice services, faces significant regulatory changes. CMS's proposed rule for 2026 indicates a trend towards reduced reimbursement rates, which could pressure margins for providers like Aveanna. The broader legislative changes from the One Big Beautiful Bill Act also signal a tightening of federal Medicaid spending, potentially impacting a key funding source. Companies in this sector must adapt to value-based care models and manage labor costs amidst shortages of qualified personnel. Aveanna's strategic acquisitions, like Thrive, and debt refinancing efforts are aimed at strengthening its market position and financial stability in this evolving landscape.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• An arbitration award of $7.9 million against the company related to a Texas non-subscriber benefit plan claim was settled in May 2025, resulting in a $6.2 million net reduction to Cost of Revenue for the nine-month period ended September 27, 2025.
• The company is cooperating with a grand jury subpoena issued by the U.S. Department of Justice, Antitrust Division, since October 30, 2019, regarding nurse wages, reimbursement rates, and hiring activities in certain local markets. Management believes a loss event is not probable.
• The company is cooperating with a Civil Investigation Demand issued by the U.S. Department of Justice, Middle District of Alabama, since July 19, 2023, concerning Comfort Care Hospice, LLC, regarding alleged improper Medicare claims and remuneration for patient referrals. Management believes a loss event is not probable.

Related Party Transactions

• As of September 27, 2025, one of the company's significant shareholders owned 7.8% of the 2025 Term Loans.

Stakeholder Impact

• Shareholders: Positive impact from improved net income and shift to positive equity, but potential dilution from increased outstanding shares and future regulatory risks.
• Employees: Potential impact from ongoing DOJ Antitrust investigation into nurse wages and hiring activities.
• Customers/Patients: Potential impact from CMS reimbursement changes and Medicaid eligibility changes, which could affect service availability or scope.
• Creditors: Debt refinancing extends maturities and improves the debt profile, enhancing security for lenders, though a loss on extinguishment was recognized.
• Regulatory Authorities: Ongoing scrutiny from DOJ and CMS indicates a high level of regulatory engagement and compliance requirements.

Next Steps

• The company will continue to evaluate the full extent of the impact of the One Big Beautiful Bill Act.
• Management will continue to cooperate with the U.S. Department of Justice, Antitrust Division, regarding the grand jury subpoena.
• Management will continue to cooperate with the U.S. Department of Justice, Middle District of Alabama, regarding the Civil Investigation Demand for Comfort Care Hospice, LLC.
• The company plans to adopt ASU 2023-09 (Income Taxes) for its fiscal year 2025 annual financial statements.
• The company is evaluating the impact of ASU 2024-03 (Disaggregation of Income Statement Expenses) for adoption in its 2027 annual report.

Key Dates

Recommendation

Aveanna Healthcare Holdings Inc. demonstrated strong financial performance in Q3 2025, with significant revenue and net income growth, and successfully refinanced its debt, improving its capital structure. The shift from a stockholders' deficit to positive equity is a notable positive. However, the company faces material regulatory headwinds, including anticipated Medicare payment reductions and broader Medicaid spending cuts, which could impact future profitability. Ongoing legal investigations also introduce uncertainty. While current performance is robust, these future risks warrant a cautious 'hold' stance, allowing investors to monitor the impact of regulatory changes and the resolution of legal matters before making further investment decisions.

Keywords

Healthcare, Home Health, Hospice, Pediatric Care, Medical Solutions, SEC Filing, 10-Q, Financial Results, Revenue Growth, Net Income, Debt Refinancing, Acquisition, Thrive Skilled Pediatric Care, Medicaid, Medicare, Regulatory Risk, OBBBA, CMS, Corporate Debt, AVAH